November 18, 2026
Health news, explained with evidence
LIVE

FDA Moves to Withdraw Approval for Liquid Simvastatin Suspension

🧠 Mind & Mental Health 1 min read 👁 2

The FDA has initiated proceedings to remove FloLipid, a liquid form of the statin simvastatin, from the market after the manufacturer repeatedly failed to submit mandatory annual reports.

FDA Moves to Withdraw Approval for Liquid Simvastatin Suspension🧠Mind & Mental Health

Photo: medpagetoday.com

Key points

  • The FDA is seeking to withdraw approval for FloLipid, a liquid simvastatin suspension.
  • The action stems from the manufacturer's repeated failure to submit mandatory annual reports.
  • Patients and doctors can explore alternative liquid options, such as atorvastatin oral suspension.

Federal regulators have announced plans to withdraw approval for simvastatin oral suspension, marketed under the brand name FloLipid, due to regulatory non-compliance by manufacturer Salerno Pharma. According to a notice published in the Federal Register by top FDA drug regulator Michael Davis, MD, PhD, the company has consistently neglected to file required annual reports that detail necessary labeling updates, chemistry data, and manufacturing specifications. The agency is providing the drugmaker an opportunity to request a formal hearing before finalizing the withdrawal.

Initially cleared by regulators in 2016, the oral suspension was designed specifically to help patients who struggle with swallowing traditional pills manage their LDL cholesterol levels. While the medication provided a liquid alternative, statin therapies carry recognized safety considerations, including potential risks of myopathy and rhabdomyolysis at higher doses, alongside rare reports of immune-mediated necrotizing myopathy added to the product label in 2020. Patients currently utilizing liquid statin formulations who have concerns regarding their treatment plan should consult a healthcare provider to discuss alternative options, such as other available liquid cholesterol medications like atorvastatin oral suspension.

Source medpagetoday.com — medpagetoday.com/cardiology/dyslipidemia/123922 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.